Astellas Partners with Adaptimmune on “Off-the-shelf” Cell Therapies
By Michelle Liu
Pharma Deals Review: Vol 2020 Issue 1 (Table of Contents)
Published: 21 Jan-2020
DOI: 10.3833/pdr.v2020.i1.2501 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
In a move to bolster its cell therapies offering, Astellas has agreed to partner with Adaptimmune Therapeutics to co-develop and co-commercialise up to three stem-cell derived allogeneic T-cell therapies...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS